{"id":11473,"date":"2024-03-25T09:21:05","date_gmt":"2024-03-25T08:21:05","guid":{"rendered":"https:\/\/leo-foundation.org\/en\/?p=11473"},"modified":"2024-03-25T17:51:20","modified_gmt":"2024-03-25T16:51:20","slug":"annual-report-2023-achievements-and-ambitions-that-pave-the-way-for-curing-skin-diseases","status":"publish","type":"post","link":"https:\/\/leo-foundation.org\/en\/2024\/03\/25\/annual-report-2023-achievements-and-ambitions-that-pave-the-way-for-curing-skin-diseases\/","title":{"rendered":"Annual Report 2023: Achievements and ambitions that pave the way for curing skin diseases"},"content":{"rendered":"\n
\n
\n
<\/div>\n\n\n
\n \n\n
\n

25 March 2024<\/em><\/p>\n\n\n\n

2023 was a year of significant achievements, alongside setting clear ambitions toward 2030 that guide the LEO Foundation\u2019s work as an enterprise foundation, owner, philanthropist and investor. These achievements and clarity on our ambitions highlight our commitment to do our part in paving the way for curing skin diseases.<\/strong><\/strong><\/strong><\/strong><\/p>\n\n\n\n

The LEO Foundation had a successful year in terms of both philanthropy and commercial activities in 2023. The grant level increased substantially, LEO Pharma achieved a strong uplift in operating performance, and the financial investments generated solid returns.<\/p>\n\n\n\n

2023 highlights:<\/strong><\/p>\n\n\n\n